TREM2 Antikörper (AA 19-161)
-
- Target Alle TREM2 Antikörper anzeigen
- TREM2 (Triggering Receptor Expressed On Myeloid Cells 2 (TREM2))
-
Bindungsspezifität
- AA 19-161
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser TREM2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Aufreinigung
- TREM2 antibody was purified by protein-G affinity chromatography
- Immunogen
- TREM2 antibody was raised in mouse using recombinant human TREM2 (19-161aa) purified from E. coli as the immunogen.
- Klon
- 2B5
- Isotyp
- IgG3 kappa
- Top Product
- Discover our top product TREM2 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- as a liquid PBS, pH 7.4, with 0.1 % NaN3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze/thaw cycles
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices." in: Brain pathology (Zurich, Switzerland), Vol. 25, Issue 4, pp. 469-80, (2016) (PubMed).
: "
-
TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices." in: Brain pathology (Zurich, Switzerland), Vol. 25, Issue 4, pp. 469-80, (2016) (PubMed).
-
- Target
- TREM2 (Triggering Receptor Expressed On Myeloid Cells 2 (TREM2))
- Andere Bezeichnung
- TREM2 (TREM2 Produkte)
-